These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 417479)

  • 1. [Effect of infection on the immune system in burns in animal experiments].
    Böhland W; Sauer D
    Z Exp Chir; 1978; 11(1):32-6. PubMed ID: 417479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of various steroid hormones on the course of pseudomonas infections in 3rd grade burns].
    Seitz HD; Wiehler S
    Z Exp Chir; 1979 Apr; 12(2):94-101. PubMed ID: 112791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitization to Pseudomonas aeruginosa in thermal burn patients].
    Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS
    Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796
    [No Abstract]   [Full Text] [Related]  

  • 6. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral antibody response to Pseudomonas aeruginosa in a burned mouse model.
    Subramaniam L; Shriniwas ; Kumar R; Bhujwala RA
    Indian J Med Res; 1985 Dec; 82():498-501. PubMed ID: 3938772
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
    Pallua N; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arthritis in burned persons, caused by Pseudomonas aeruginosa].
    Orlov AN; Baliabin AA; Krasnopevtseva OS
    Vestn Khir Im I I Grek; 1975 Nov; 115(11):98-100. PubMed ID: 813351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa.
    Balloy V; Verma A; Kuravi S; Si-Tahar M; Chignard M; Ramphal R
    J Infect Dis; 2007 Jul; 196(2):289-96. PubMed ID: 17570117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific immunity in patients with severe burns complicated by Pseudomonas infection].
    Fedorovskaia EA; Nazarchuk LV
    Klin Khir (1962); 1989; (3):35-7. PubMed ID: 2733361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pseudomonas infection following burn injuries with specific antitoxic Ig-therapy].
    Städtler K; Allgöwer M; Burkhardt F; Vogt P; Wüest B; Schoenenberger GA
    Langenbecks Arch Chir; 1975; Suppl():169-72. PubMed ID: 1207225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
    Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
    Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonspecific prophylaxis and therapy of Pseudomonas aeruginosa wound-infections with paramunization using a mouse-model (author's transl)].
    Mayr A; Himmer B; Baljer G; Sailer J
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):506-14. PubMed ID: 232340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infections model involving the mouse in experimental burns].
    Böhland W; Sauer D; Linde K; Pietsch G
    Z Exp Chir; 1978; 11(1):11-6. PubMed ID: 417478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evidence for a significant impairment of host defense for gram-negative organisms by a specific cutaneous toxin produced by severe burn injuries.
    Schoenenberger GA; Burkhardt F; Kalberer F; Müller W; Städtler K; Vogt P; Allgöwer M
    Surg Gynecol Obstet; 1975 Oct; 141(4):555-61. PubMed ID: 1166380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.